Chinese expert consensus for assessment of cardiovascular risk in asymptomatic adults

Chinese Journal of Cardiology

Volumn 41, Issue 10, 2013, Pages 820-824

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CHINESE; CONSENSUS; HUMAN;

EID: 84891885517     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2013.10.003     Document Type: Article

References (36)

1. World Health Organization. Prevention of cardiovascular disease. Guidelines for Assessment and Management of Cardiovascular Risk. Geneva: WHO Press, 2007.
2. Conroy R M, Pyörälä K, Fitzgerald A P, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J, 2003, 24:987-1003.
3. Greenland P, Alpert J S, Beller G A, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol, 2010, 56: e50-e103.
4. 2011, 39:3-22.
5. 2010, 49:174-185.
6. D'Agostino R B Sr, Grundy S, Sullivan L M, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA, 2001, 286: 180-187.
7. Hawe E, Talmud P J, Miller G J, et al. Family history is a coronary heart disease risk factor in the second Northwick Park heart study. Ann Hum Genet, 2003, 67:97-106.
8. Lloyd-Jones D M, Nam B H, D'Agostino R B Sr, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA, 2004, 291:2204-2211.
9. Ridker P M, Buring J E, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA, 2007, 297:611-619.
10. Danesh J, Wheeler J G, Hirschfield G M, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med, 2004, 350:1387-1397.
11. Albert C M, Ma J, Rifai N, et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation, 2002, 105:2595 -2599.
12. Aviles R J, Martin D O, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation, 2003, 108:3006-3010.
13. Ridker P M, Danielson E, Fonseca F A, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008, 359:2195-2207.
14. Ridker P M, Paynter N P, Rifai N, et al. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation, 2008, 118: 2243-2251.
15. Baigent C, Keech A, Kearney P M, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet, 2005, 366:1267-1278.
16. Khaw K T, Wareham N, Bingham S, et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med, 2004, 141:413-420.
17. Selvin E, Steffes M W, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med, 2010, 362:800-811.
18. Perkovic V, Verdon C, Ninomiya T, et al. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med, 2008, 5: e207.
19. Graham I M, Daly L E, Rersum H M, et al. Plasma homocysteine as a risk factor for vascular disease. The European concerted action project. JAMA, 1997, 277: 1775-1781.
20. Ashley E A, Raxwal V, Froelicher V. An evidence-based review of the resting electrocardiogram as a screening technique for heart disease. Prog Cardiovasc Dis, 2001, 44:55-67.
21. Gorodeski E Z, Ishwaran H, Blackstone E H, et al. Quantitative electrocardiographic measures and long-term mortality in exercise test patients with clinically normal resting electrocardiograms. Am Heart J, 2009, 158:61-70.
22. Lauer M, Froelicher E S, Williams M, et al. Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation, 2005, 112:771-776.
23. Frolkis J P, Pothier C E, Blackstone E H, et al. Frequent ventricular eclopy after exercise as a predictor of death. N Engl J Med, 2003, 348:781-790.
24. Verdecchia P, Carini G, Circo A, et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol, 2001, 38:1829-1835.
25. Lorenz M W, Markus H S, Bots M L, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation, 2007, 115:459-467.
26. Belcaro G, Nicolaides A N, Ramaswami G, et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study [the CAFES-CAVE study(1)]. Atherosclerosis, 2001, 156:379-387.
27. Nambi V, Chambless L, Folsom A, et al. Carotid intima-media thickness and the presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (atherosclerosis risk in communities) study. J Am Coll Cardiol, 2010, 55:1600-1607.
28. Witte D R, Westerink J, de Koning E J, et al. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?. J Am Coll Cardiol, 2005, 45:1987-1893.
29. Folsom A R, Kronmal R A, Detrano R C, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med, 2008, 168: 1333-1339.
30. Fowkes F G, Murray G D, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA, 2008, 300: 197-208.
31. Nakajima K, Yamasaki Y, Kusuoka H, et al. Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging. Eur J Nucl Med Mol Imaging, 2009, 36:2049-2057.
32. Odink A E, van der Lugt A, Hofman A, et al. Association between calcification in the coronary arteries, aortic arch and carotid arteries: the Rotterdam study. Atherosclerosis, 2007, 193: 408-413.
33. Detrano R, Guerci A D, Carr J J, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med, 2008, 358:1336-1345.
34. Nasir K, Budoff M J, Post W S, et al. Electron beam CT versus helical CT scans for assessing coronary calcification: current utility and future directions. Am Heart J, 2003, 146:969-977.
35. Greenland P, Bonow R O, Brundage B H, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation clinical expert consensus task force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography). J Am Coll Cardiol, 2007, 49:378-402.
36. Bluemke D A, Achenbach S, Budoff M, et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American heart association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation, 2008, 118:586-606.